Home

John A Sedor

CIK 1337409 · Chairman of Board and CEO · last filed 2018-08-10

John A Sedor is a Chairman of Board and CEO who has filed 19 SEC Form 4 insider transactions across 2 companies since 2007. The most recent filing shows the insider had shares withheld for taxes covering $1.3K of PTX on Aug 10, 2018. Current disclosed insider exposure totals $465.4K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$465.4K

Companies

2

Total Filings

19

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted Chairman of Board and CEO 133,140 — — $0 9 2018-08-10
BNT President 11,027 $42.21 $465.4K $0 2 2008-05-23

Recent Filings

19 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2018-08-10 PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted Tax (F) −685 -$1.3K EDGAR
2018-07-27 PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted Tax (F) −11,982 -$30.3K EDGAR
2018-03-16 PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted Grant (A) +18,000 $0 EDGAR
2017-08-09 PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted Grant (A) +10,000 $0 EDGAR
2017-07-31 PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted Tax (F) −13,293 -$41.9K EDGAR
2016-11-07 PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted Grant (A) +131,100 $0 EDGAR
2016-05-11 PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted Grant (A) — $0 EDGAR
2015-08-18 PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted Grant (A) — $0 EDGAR
2014-03-14 PERNIX THERAPEUTICS HOLDINGS, INC. (PTX) Delisted Grant (A) — $0 EDGAR
2011-04-07 — Mixed −19,847 -$2.20M
Showing 1–10 of 19
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.